About SomaLogic, Inc. (SLGC) — Dividend Analysis 2026
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.
Is SLGC a good dividend investment in 2026?
SLGC offers a 95.24% forward yield with a 50% payout ratio. Strand Safety Score: 0/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
SLGC DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your SLGC portfolio grows to $23.52M vs $10.34M without reinvestment. This is the compound interest effect in action.
SLGC dividend growth history & forecast
SLGC has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 95.24%.
Company generates negative FCF ($-106M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.1B → -0.1B → -0.1B
0 / 30 pts
0/30
Company is reporting net losses — dividend sustainability is in question
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
0
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 SLGC Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SLGC.
Gross yield
95.24%
Tax rate
15.00%
After-tax yield
80.95%
Real yield (−CPI)
78.15%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
95.24%
92.44%
$9,524 / yr
🇺🇸 US Taxable (15%) ✓
15%
80.95%
78.15%
$8,095 / yr
🇺🇸 US Taxable (20%)
20%
76.19%
73.39%
$7,619 / yr
🇬🇧 UK ISA
0%
95.24%
92.44%
$9,524 / yr
🇬🇧 UK Taxable
8.75%
86.91%
84.11%
$8,691 / yr
🇨🇦 TFSA
0%
95.24%
92.44%
$9,524 / yr
🇨🇦 CA Taxable
25%
71.43%
68.63%
$7,143 / yr
🇦🇺 Super (pension)
15%
80.95%
78.15%
$8,095 / yr
🇦🇺 AU Taxable
30%
66.67%
63.87%
$6,667 / yr
🇩🇪 DE Taxable
26.375%
70.12%
67.32%
$7,012 / yr
🇫🇷 FR Taxable
30%
66.67%
63.87%
$6,667 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SLGC Income Goal & Break-Even
Dividend Break-Even
2yr
Years for dividends to fully repay your SLGC investment of $2.10/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$146.4K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$143.9K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in SLGC for:
Shares needed
14,118
Capital required
$29,648
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SLGC Dividend Payment Schedule
SLGC pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 SLGC vs Healthcare Benchmarks
How SLGC compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+92.44% vs sectorBetter
SLGC
95.24%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
SLGC
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
SLGC
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SLGC sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SLGC Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
110,000
$9.08
$998.8K
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
185,812
$13.27
$2.47M
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
95,000
$2.33
$221.3K
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
48,425
$0.00
$5.00
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
855,000
$2.74
$2.34M
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
145,000
$3.79
$549.5K
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
592,000
—
—
Taich Adam
officer: Interim CEO
D-Return
2024-01-05
150,000
$2.30
$345.0K
Ryan Jason
director
D-Return
2024-01-05
14,650
$2.74
$40.1K
Ryan Jason
director
D-Return
2024-01-05
3,400
—
—
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
🎯
Analyst Price Target
Wall Street consensus
Current Price
$2.10
Analyst Target
$12.00
Upside / Downside
+471.4%
Range
$9.00 – $15.00
💡 If SLGC reaches the analyst target of $12.00, investors buying today at $2.10 would see an effective yield of 16.67% on shares purchased at target price — vs 95.24% at current price.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
🔬
Financial Health Scores
Altman Z-Score
2.06
⚠️ Grey Zone — monitor closely
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
2/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SLGC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →